[en] SCOPE: Binge consumption of alcohol is an alarming global health problem. Acute ethanol intoxication is characterized by inflammation and oxidative stress, which could be promoted by gut barrier function alterations. In this study, we have tested the hypothesis of the hepatoprotective effect of rhubarb extract in a mouse model of binge drinking and we explored the contribution of the gut microbiota in the related- metabolic effects. METHODS AND RESULTS: Mice were fed a control diet supplemented with or without 0.3% rhubarb extract for 17 days and were necropsied 6 hours after an alcohol challenge. Supplementation with rhubarb extract changed the microbial ecosystem (assessed by 16S rDNA pyrosequencing) in favor of Akkermansia muciniphila and Parabacteroides goldsteinii. Furthermore, it improved alcohol-induced hepatic injury, down-regulated key markers of both inflammatory and oxidative stresses in the liver tissue, without affecting significantly steatosis. In the gut, rhubarb supplementation increased crypt depth, tissue weight, the expression of antimicrobial peptides. CONCLUSIONS: These findings suggest that some bacterial genders involved in gut barrier function, are promoted by phytochemicals present in rhubarb extract, and could therefore be involved in the modulation of the susceptibility to hepatic diseases linked to acute alcohol consumption. This article is protected by copyright. All rights reserved.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Neyrinck, Audrey M.
Etxeberria, Usune
Taminiau, Bernard ; Université de Liège > Département de sciences des denrées alimentaires (DDA) > Microbiologie des denrées alimentaires
Daube, Georges ; Université de Liège > Département de sciences des denrées alimentaires (DDA) > Microbiologie des denrées alimentaires
Van Hul, Matthias
Everard, Amandine
Cani, Patrice D.
Bindels, Laure B.
Delzenne, Nathalie M.
Language :
English
Title :
Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota.
Publication date :
2017
Journal title :
Molecular Nutrition and Food Research
ISSN :
1613-4125
eISSN :
1613-4133
Publisher :
John Wiley & Sons, United Kingdom
Volume :
61
Issue :
1
Pages :
1500899
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
NUTRIGUTIOR
Funders :
DGTRE - Région wallonne. Direction générale des Technologies, de la Recherche et de l'Énergie
Commentary :
This article is protected by copyright. All rights reserved.
Shukla, S. D., Pruett, S. B., Szabo, G., Arteel, G. E., Binge ethanol and liver: new molecular developments. Alcohol Clin. Exp. Res. 2013, 37, 550–557.
Dugum, M., McCullough, A., Diagnosis and management of alcoholic liver disease. J. Clin. Transl. Hepatol. 2015, 3, 109–116.
Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B. et al., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 2008, 44, 1259–1272.
Donohue, T. M. Jr., Osna, N. A., Trambly, C. S., Whitaker, N. P. et al., Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcohol Clin. Exp. Res. 2012, 36, 759–767.
Donohue, T. M. Jr., Alcohol-induced steatosis in liver cells. World J. Gastroenterol. 2007, 13, 4974–4978.
Stewart, S., Jones, D., Day, C. P., Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol. Med. 2001, 7, 408–413.
Marmier, S., Dentin, R., Daujat-Chavanieu, M., Guillou, H. et al., Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 2015, 62, 1086–1100.
Vassallo, G., Mirijello, A., Ferrulli, A., Antonelli, M. et al., Review article: alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Aliment. Pharmacol. Ther. 2015, 41, 917–927.
Massey, V. L., Arteel, G. E., Acute alcohol-induced liver injury. Front. Physiol. 2012, 3, 193.
Canesso, M. C. C., Lacerda N. L., Ferreira C. M., Gonçalves J. L. et al., Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol. 2014, 14, 240.
Hammer, A. M., Khan, O. M., Morris, N. L., Li, X. et al., The effects of alcohol intoxication and burn injury on the expression of claudins and mucins in the small and large intestines. Shock 2016, 45, 73–81.
Leclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M. et al., Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U S A 2014, 111, E4485–E4493.
Gao, B., Bataller, R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141, 1572–1585.
Pan, M. H., Lai, C. S., Ho, C. T., Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010, 1, 15–31.
Yao, L. H., Jiang, Y. M., Shi, J., Tomas-Barberan, F. A. et al., Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59, 113–122.
Ding, R. B., Tian, K., Huang, L. L., He, C. W. et al., Herbal medicines for the prevention of alcoholic liver disease: a review. J. Ethnopharmacol. 2012, 144, 457–465.
Huang, Q., Lu, G., Shen, H. M., Chung, M. C. et al., Anti-cancer properties of anthraquinones from rhubarb. Med. Res. Rev. 2007, 27, 609–630.
Zhao, Y. L., Wang, J. B., Zhou, G. D., Shan, L. M. et al., Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats. Basic Clin. Pharmacol. Toxicol. 2009, 104, 463–469.
Bindels, L. B., Neyrinck, A. M., Salazar, N., Taminiau, B. et al., Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS One 2015, 10, e0131009.
Neyrinck, A. M., Possemiers, S., Verstraete, W., De, B. F. et al., Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J. Nutr. Biochem. 2012, 23, 51–59.
Esterbauer, H., Cheeseman, K. H., Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186, 407–421.
Szabados, E., Fischer, G. M., Toth, K., Csete, B. et al., Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic. Biol. Med. 1999, 26, 309–317.
De, C. C., Oevermann, A., Burgener, I. A., Doherr, M. G. et al., Gastrointestinal tract mucosal histomorphometry and epithelial cell proliferation and apoptosis in neonatal and adult dogs. J. Anim. Sci. 2010, 88, 2255–2264.
Kitazawa, H., Nishihara, T., Nambu, T., Nishizawa, H. et al., Intectin, a novel small intestine-specific glycosylphosphatidylinositol-anchored protein, accelerates apoptosis of intestinal epithelial cells. J. Biol. Chem. 2004, 279, 42867–42874.
Cliffe, L. J., Humphreys, N. E., Lane, T. E., Potten, C. S. et al., Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005, 308, 1463–1465.
Rao, R. K., Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol. Biol. 2008, 447, 171–183.
Wang, Y., Liu, Y., Sidhu, A., Ma, Z. et al., Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am. J. Physiol Gastrointest. Liver Physiol. 2012, 303, G32–G41.
Turner, J. R., Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9, 799–809.
Schnabl, B., Brenner, D. A., Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014, 146, 1513–1524.
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W. et al., Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995, 108, 218–224.
Ferrier, L., Berard, F., Debrauwer, L., Chabo, C. et al., Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am. J. Pathol. 2006, 168, 1148–1154.
Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L. et al., Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010, 104 (Suppl 2), S1–63.
Duenas, M., Munoz-Gonzalez, I., Cueva, C., Jimenez-Giron, A. et al., A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015, 2015, 850902.
Anhe, F. F., Varin, T. V., Le, B. M., Desjardins, Y. et al., Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts. Curr. Obes. Rep. 2015, 4, 389–400.
Yan, A. W., Fouts, D. E., Brandl, J., Starkel, P. et al., Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011, 53, 96–105.
Gallo, R. L., Hooper, L. V., Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 2012, 12, 503–516.
Everard, A., Lazarevic, V., Gaia, N., Johansson, M. et al., Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014, 8, 2116–2130.
Vereecke, L., Beyaert, R., van, L. G., Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol. Med. 2011, 17, 584–593.
Khan, I. A., Nasiruddin, M., Haque, S. F., Khan, R. A., Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial. Int. J. Chronic Dis. 2014, 2014, 789340.
Hasper, I., Ventskovskiy, B. M., Rettenberger, R., Heger, P. W. et al., Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause 2009, 16, 117–131.
Ding, Y., Zhao, L., Mei, H., Zhang, S. L. et al., Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol. 2008, 590, 377–386.
Arosio, B., Gagliano, N., Fusaro, L. M., Parmeggiani, L. et al., Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol. Toxicol. 2000, 87, 229–233.
Jin, H., Sakaida, I., Tsuchiya, M., Okita, K., Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Life Sci. 2005, 76, 2805–2816.
Wang, J. B., Zhao, H. P., Zhao, Y. L., Jin, C. et al., Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One 2011, 6, e24498.
Wang, J., Zhao, Y., Xiao, X., Li, H. et al., Assessment of the renal protection and hepatotoxicity of rhubarb extract in rats. J. Ethnopharmacol. 2009, 124, 18–25.
Dryden, G. W. Jr., Deaciuc, I., Arteel, G., McClain, C. J., Clinical implications of oxidative stress and antioxidant therapy. Curr. Gastroenterol. Rep. 2005, 7, 308–316.
Morgan, K., French, S. W., Morgan, T. R., Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 2002, 36, 122–134.
Kono, H., Rusyn, I., Yin, M., Gabele, E. et al., NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest 2000, 106, 867–872.
Ceccarelli, S., Nobili, V., Alisi, A., Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J. Gastroenterol. 2014, 20, 16443–16451.
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U. et al., Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001, 34, 101–108.
Beutler, B., Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 2009, 227, 248–263.
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P. et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U S A 2013, 110, 9066–9071.
Everard, A., Lazarevic, V., Derrien, M., Girard, M. et al., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60, 2775–2786.
Chang, C. J., Lin, C. S., Lu, C. C., Martel, J. et al., Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 2015, 6, 7489.
Delzenne, N. M., Bindels, L. B., Gut microbiota: Ganoderma lucidum, a new prebiotic agent to treat obesity? Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 553–554.
